Ragusi, M. A., Bismeijer, T., Velden, B. H. v. d., Loo, C. E., Canisius, S., Wesseling, J., . . . Gilhuijs, K. G. (2021). Contralateral parenchymal enhancement on MRI is associated with tumor proteasome pathway gene expression and overall survival of early ER+/HER2-breast cancer patients. Elsevier.
Style de citation Chicago (17e éd.)Ragusi, Max A.A., Tycho Bismeijer, Bas H.M. van der Velden, Claudette E. Loo, Sander Canisius, Jelle Wesseling, Lodewyk F.A Wessels, Sjoerd G. Elias, et Kenneth G.A Gilhuijs. Contralateral Parenchymal Enhancement on MRI Is Associated with Tumor Proteasome Pathway Gene Expression and Overall Survival of Early ER+/HER2-breast Cancer Patients. Elsevier, 2021.
Style de citation MLA (8e éd.)Ragusi, Max A.A., et al. Contralateral Parenchymal Enhancement on MRI Is Associated with Tumor Proteasome Pathway Gene Expression and Overall Survival of Early ER+/HER2-breast Cancer Patients. Elsevier, 2021.